Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

In China, Roche and Swiss Re Offer Insurance to Cover Biologic Drugs

publication date: Nov 14, 2012
To increase China sales of its biologic drugs, Roche is using a strategy that works in the west: insurance. The company is working with Swiss Re to offer insurance at a nominal amount to China’s residents. Although China offers a basic level of insurance to its citizens, the plans do not cover Roche’s high-priced cancer drugs. So far, according to a Bloomberg article, six million Chinese have signed up, and ten million are expected before the end of the year. More details....

Stock Symbol: (VX: ROG)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital